| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: what is presented is application of a 1-aminoalkyltcyclohexane derivative specified in neramexane or its pharmaceutically acceptable salt for preparing a drug for preventing and/or treating hearing loss, except for drug-induced hearing loss, application thereof for preventing and/or treating hearing loss, except for drug-induced hearing loss and a pharmaceutical composition for the same application. ^ EFFECT: auditory threshold extension after 4 months of the therapy with neramexane 50 mg a day is shown. ^ 27 cl, 1 dwg, 1 tbl, 2 ex |
